Key Takeaways
- Staphyt and GenoScreen have signed a strategic collaboration agreement.
- The partnership integrates genomics, regulatory studies, and field trials into a single offering.
- The collaboration targets agro-industry and biosolutions companies developing microbial products.
- The joint approach supports product development from proof-of-concept to regulatory validation.
- Both organizations aim to address growing regulatory and scientific complexity in agriculture.
Staphyt and GenoScreen Establish Integrated Service Model for Agriculture
Staphyt, a contract research organization and regulatory affairs consultant specializing in agricultural experimentation and risk assessment, and GenoScreen, a provider of genomic and bioinformatics solutions, have announced a strategic collaboration agreement.
The partnership brings together GenoScreen’s genomic technologies with Staphyt’s expertise in regulatory studies and experimental trials. According to the companies, the objective is to provide agro-industry and biosolutions stakeholders with an integrated solution that supports the full product development lifecycle, from early scientific validation to regulatory field trials.
Addressing Regulatory and Scientific Demands in Biosolutions
The development of microbial products, including biostimulants and biocontrol solutions, increasingly depends on precise genomic characterization. These analyses are required to meet European regulatory standards related to identification, traceability, safety, and efficacy.
Industry stakeholders face growing pressure to generate robust scientific evidence demonstrating not only the identity of microorganisms, but also their effects on soil and plant health. Without detailed genomic data, regulatory approval and market authorization are difficult to obtain.
The partnership between Staphyt and GenoScreen is intended to respond to these challenges by combining genomic analysis with regulatory-compliant experimentation.
A Unified Value Chain From Genomics to Field Validation
Expanded Capabilities for Both Organizations
Under the collaboration, GenoScreen will extend its service offering by leveraging Staphyt’s regulatory and experimental capabilities, including:
- Management of marketing authorization applications with regulatory authorities
- Conducting efficacy trials in open fields, greenhouses, and controlled environments
- Performing laboratory studies such as ecotoxicology and analytical chemistry in line with regulatory standards
At the same time, Staphyt will strengthen its scientific capabilities through access to GenoScreen’s expertise in:
- Microbial and regulatory genomics
- Sequencing and bioinformatics analysis of microorganisms and plants
- Development of genetic tools, including qPCR assays, gene expression studies, and soil microbiome impact assessments
This combined approach is designed to deliver controlled, traceable, and regulator-ready data for agricultural innovations.
Staphyt & GenoScreen Leadership Perspectives on the Collaboration
“With this partnership, we aim to offer our clients an integrated experience where scientific rigor meets regulatory mastery,” said Téo Fournier, Director of the Solutions and Services Department at GenoScreen. “By uniting our know-how, GenoScreen and Staphyt are creating a continuum from field trials to genomic data entirely focused on regulatory proof.”
Olivier Marchioro, CEO of Staphyt, emphasized the strategic rationale behind the agreement: “The collaboration between Staphyt and GenoScreen is a natural extension of our strategy to build partnerships in complementary fields that support innovation. This partnership responds to a growing client need to link genetic understanding with research and development studies in controlled conditions or open fields for regulatory data.”
Supporting Innovation in Agricultural Biosolutions
Both companies stated that the partnership is designed to help developers of agricultural biosolutions navigate increasingly complex regulatory frameworks while maintaining scientific credibility. By integrating genomics, experimentation, and regulatory expertise, Staphyt and GenoScreen aim to support the development and approval of innovative, compliant solutions for sustainable agriculture.
